Ebasil? 20 contains ebastine, a long-acting, second-generation antihistamine used in the management of allergic conditions such as seasonal allergic rhinitis, perennial allergic rhinitis, and chronic idiopathic urticaria. Ebastine works by selectively blocking peripheral H1 histamine receptors, thereby preventing the action of histamine, a key mediator responsible for allergy symptoms such as sneezing, itching, runny nose, watery eyes, and skin wheals.

Unlike first-generation antihistamines, Ebasil? 20 has minimal penetration into the central nervous system, resulting in very low sedation and making it suitable for daytime use. Its long duration of action provides effective 24-hour symptom control with once-daily dosing, improving patient compliance and quality of life.